News & Events

CDI in the News

February 21, 2020

MADISON, Wis.–(BUSINESS WIRE)–Stemina Biomarker Discovery, Inc., today announced study results showing the high performance of the company’s Cardio quickPredict test in identifying cardiotoxic effects for a large number of well-characterized drugs. These results suggest the drug screening test could provide drug developers with an early, highly accurate and more comprehensive evaluation of cardiovascular toxicity.

Stemina’s Human Induced Pluripotent Stem Cell Test Predicts Drug Cardiovascular Toxicity
October 1, 2019

University of Wisconsin – Madison News

Moving beyond hype: Could one-two treatment restore damaged heart muscle?
November 18, 2017

Wisconsin State Journal

A Decade After Stem Cell Feat, Research Ramps Up
September 29, 2016

Wisconsin State Journal

CDI Creates Company to Develop Drugs to Fight Retinal Diseases
September 27, 2016

Bioscience Technology

Cell Banking in the Era of Reprogramming
September 2, 2016

Milwaukee Journal Sentinel

Cellular Dynamics Developing Therapies
June 22, 2016

Milwaukee Journal Sentinel

Cellular Dynamics Makes Hire to Prepare for Stem Cell Therapies

Pageof 4